Skip to / Accesskeys: Site Menu - 1 | Main Content - 2 or Back to Top - 3.

Dr. Robert Baiocchi

Dr. Robert Baiocchi, MD, PhD

Dr. Robert Baiocchi Division of Hematology & Oncology
Assistant Professor of Internal Medicine

Email: robert.baiocchi@osumc.edu
Phone: 614-293-6154
Lab: 614-293-7493
Fax: 614-293-4553
Pager: (614) 346-5026
Address: 1232B James Cancer Hospital
               300 W 10th Avenue
               Columbus, OH 43210

Biography:

Dr. Baiocchi earned his medical degree at The Ohio State University and his Ph.D. in Physiology at State University of New York at Buffalo. He completed his Internal Medicine residency and fellowship in Medical Oncology at The Ohio State University. Dr. Baiocchi joined the faculty in the Department of Internal Medicine, Division of Hematology and Oncology at The Ohio State University in 2004.

Dr. Baiocchi's research interests involve the immunobiology and epigenetics of viral associated malignancies in patients with underlying immune deficiency. He joined The Ohio State University's Viral Oncogenesis Program this year and is focusing his research efforts primarily on Epstein-Barr virus (EBV)-associated lymphomas. He is currently working to understand how new classes of drugs that target epigenetic processes affect cellular and viral gene expression and cell death/survival pathways. He is also collaborating with the laboratory of Dr. Michael Caligiuri to devise a vaccine to prevent EBV-associated diseases.

Dr. Baiocchi's clincal practice is dedicated to the treatment of leukemia/lymphoma. He is the institutional principal investigator for the National AIDS Malignancy Consortium and manages patients with AIDS malignancies in his outpatient clinic. Dr. Baiocchi also works with Dr. Pierluigi Porcu, Dr. Charles Eisenbies and physicians on the medical and surgical solid organ transplant teams here at OSU to manage patients with post transplant lymphoprolifertive diseases.

|back to the top|

 

Publications

Virology 346(1): 205-218, 2006
EBV-encoded dUTPase induces immune dysregulation: implications for the pathophysiology of EBV-associated disease
Glaser R, Litsky MK, Padgett DA, Baiocchi RA, Yang EV, Yang EV, Chen M, Yeh PE, Green-Church K, Caligiuri MA, Williams MV

Immunity 22(3): 295-304, 2005
A human CD34(+) subset resides in lymph nodes and differentiates into CD56(bright) natural killer cells
Freud AG, Becknell B, Roychowdhury S, Mao HC, *Ferketich AK, Nuovo GJ, Hughes TL, Marburger TB, Sung J, Baiocchi RA, Guimond M, Caligiuri MA

Blood 106(10): 3380-3382, 2005
Durable hematological complete response and suppression of HTLV-1 viral load following alemtuzumab in AZT/IFN{alpha}-refractory adult T-cell leukemia
Mone A, Puhalla S, Whitman S, Baiocchi R, Cruz J, Vukosavljevic T, Banks A, Eisenbeis CF, Byrd JC, Caligiuri MA, Porcu P

J Cutan Pathol 32(1): 35-39, 2005
Epstein-Barr virus - and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation
Verma S, Nuovo GJ, Porcu P, Baiocchi RA, Crowson AN, Magro CM

Blood 105(4): 1558-1565, 2005
IFN-gamma gene polymorphisms associate with development of EBV-positive lymphoproliferative disease in hu PBL SCID mice
Dierksheide JE, Baiocchi RA, *Ferketich AK, Roychowhury S, Pelletier S, Eisenbeis CF, Caligiuri MA, Vanbuskirk AM

Blood in press: , 2005
IL-15 but not IL-2 rapidly induces lethal xenogenetic graft versus host disease
Roychowdhury S, Blaser BW, Freud AG, Katz K, Bhatt D, Ferketich AK, Bergdall V, Kusewitt D, Baiocchi RA, Caligiuri MA

Blood 106(4): 1502-1503, 2005
Interferon (gamma) IFN-(gamma) polymorphism in posttransplantation lymphoproliferative disease
Thomas RV, McAulay K, Higgins C, Wilkie G, Crawford DH, Vanbuskirk A, Baiocchi R, Ferketich A, Gross T, Porcu P, Caligiuri MA

Brain Behav Immun 19(2): 91-103, 2005
Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer
Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, Chen M, Yeh PE, Klimas NG, Marshall GD, Whiteside T, Herberman R, Kiecolt-Glaser J, Williams MV

J Cutan Pathol 32(9): 616-612, 2005
The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy
Rawal YB, Nuovo GJ, Frambach GE, Porcu P, Baiocchi RA, Magro CM

Mol Cell Biol 25(18): 7953-7965, 2005
The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene
Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri MA, Sif S

|back to the top|